Stocks and Investing Stocks and Investing
Tue, February 13, 2024

Peter Lawson Maintained (BPMC) at Hold with Increased Target to $70 on, Feb 13th, 2024


Published on 2024-10-28 08:55:14 - WOPRAI, Peter Lawson
  Print publication without navigation


Peter Lawson of Barclays, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $58 to $70 on, Feb 13th, 2024.

Peter has made no other calls on BPMC in the last 4 months.



There are 8 other peers that have a rating on BPMC. Out of the 8 peers that are also analyzing BPMC, 1 agrees with Peter's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023


These are the ratings of the 7 analyists that currently disagree with Peter


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Tuesday, January 16th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $97 on, Tuesday, January 9th, 2024
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $100 on, Friday, December 22nd, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023
  • Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023
Contributing Sources